Starting in mid-January 2021, a mass COVID-19 vaccination campaign among residents, workers, retirees and their families has begun in the Vatican City State. During the month of December, the Directorate of Health and Hygiene decided to adopt the mRNA BNT162b2 vaccine produced by Pfizer and BioNTech, which has been shown to be 95% effective

Mass vaccination campaign for residents and workers and assistance to vulnerable populations during COVID-19 pandemic: the experience of the healthcare services of the Vatican City / Ralli, M.; De-Giorgio, F.; Soave, P. M.; Ercoli, L.; Arcangeli, A.. - In: THE LANCET REGIONAL HEALTH. EUROPE. - ISSN 2666-7762. - 2(2021). [10.1016/j.lanepe.2021.100053]

Mass vaccination campaign for residents and workers and assistance to vulnerable populations during COVID-19 pandemic: the experience of the healthcare services of the Vatican City

Ralli M.
Primo
;
2021

Abstract

Starting in mid-January 2021, a mass COVID-19 vaccination campaign among residents, workers, retirees and their families has begun in the Vatican City State. During the month of December, the Directorate of Health and Hygiene decided to adopt the mRNA BNT162b2 vaccine produced by Pfizer and BioNTech, which has been shown to be 95% effective
File allegati a questo prodotto
File Dimensione Formato  
Ralli_Mass vaccination campaign_.pdf

accesso aperto

Note: https://www.thelancet.com/journals/lanepe/article/PIIS2666-7762(21)00030-2/fulltext
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 240.94 kB
Formato Adobe PDF
240.94 kB Adobe PDF Visualizza/Apri PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11573/1577996
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 3
  • ???jsp.display-item.citation.isi??? 2
social impact